194700 — Novarex Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapSuper Stock

Market Cap
KR₩199bn
Enterprise Value
KR₩194bn
Revenue
KR₩298bn

Annual income statement for Novarex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	222,832	278,790	281,675	302,167	297,725
Cost of Revenue
Gross Profit	39,203	41,443	40,417	43,932	43,233
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	195,839	248,778	256,647	276,697	274,613
Operating Profit	26,993	30,012	25,028	25,470	23,113
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26,801	30,648	24,245	26,142	28,673
Provision for Income Taxes
Net Income After Taxes	25,000	26,313	19,942	21,974	23,838
Minority Interest
Net Income Before Extraordinary Items
Net Income	25,145	26,401	19,986	22,036	23,017
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25,145	26,401	19,986	22,036	23,017
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,554	1,636	1,216	1,249	1,287
Dividends per Share